Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) fell 2.7% on Tuesday . The stock traded as low as $2.14 and last traded at $2.14. 3,930 shares traded hands during trading, a decline of 100% from the average session volume of 842,200 shares. The stock had previously closed at $2.20.
Ampliphi Biosciences Stock Up 0.5 %
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- Stock Sentiment Analysis: How it Works
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- The How and Why of Investing in Gold Stocks
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
